Simplifying Global Compliance
FDA Returning to Original Intent on Part 11 After Confusion
Executive Briefing Series
The FDA has reopened the subject of Part 11 to examine what went wrong and how to return to the agency’s original intent.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing